UNSPSC 51182408: Cellulose sodium phosphate

This classification denotes a cation exchange resins and column chromatography, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E6S1NJ4Y5Q. European Medicines Agency schedules Sodium cellulose phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15280MIG. Cellulose sodium phosphate generally arises in the molecular formula (C6H7O5)N.NA.O3P.H. The term 'cellulose sodium phosphate' is a United States Adopted Name designation.

As of Q4 2014, CELLULOSE SODIUM PHOSPHATE remains the US FDA Preferred Term for this commodity. SMILES: NONE.

UNSPSC 51182408 Cellulose sodium phosphate (Commodity) shows no recent state and local solicitation activity aligned with the code's nominal scope. The three recent opportunities posted under this code—Collin County's offender drug testing services (RFP 2026-327, due July 23, 2026), Texas HHS's therapeutic pharmacy initiative RFI (HHS0017013, closed April 3, 2026), and MMCAP's generic pharmaceutical cooperative contract (RFP S1070000015802, due March 26, 2026)—are pharmaceutical procurement and testing service solicitations rather than purchases of cellulose sodium phosphate as a chemical ingredient or finished product. The three opportunities span different issuing bodies (a county criminal justice department, a state health agency, and a multistate cooperative purchasing alliance) and different procurement mechanisms (RFP, RFI, and cooperative RFP), but none reflects procurement demand for cellulose sodium phosphate specifically.

The mismatch between the code's chemical commodity definition and the pharmaceutical-services and generic-drug-distribution focus of recent tagged opportunities suggests either a classification error in source data or that state and local governments do not currently solicit cellulose sodium phosphate as a standalone line item under this code. No geographic concentration of cellulose sodium phosphate procurement is evident. A business development professional evaluating this code should verify whether state and local demand for the chemical itself exists outside these pharmaceutical-service solicitations, or whether opportunities under this code are systematically miscategorized in source databases.